Abeona Therapeutics Inc. (ABEO): Company Cash Volume

Symbol and logo of brand Abeona Therapeutics Inc. (ABEO)

The amount of cash and cash equivalents demonstrates the liquidity of Abeona Therapeutics (ABEO), with the 0.14 indicator determining the magnitude of the metric. Abeona Therapeutics develops unique treatments for genetic skin pathologies, aiming for long-term dominance in the niche. Success depends on the FDA certification of Pz-cel and the deployment of logistics. High demand within the narrow cell therapy segment guarantees stable product demand.

ABEO - Abeona Therapeutics Company Cash Volume over the range 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for abeonatherapeutics.com (ABEO)

- stock value and consensus price forecast:
- stock exchange capitalization data:
Analysis of all company metrics:ABEO abeonatherapeutics.com
Brand item of Abeona Therapeutics

Investors verify the financial stability of the issuer through liquidity and solvency analysis. This indicator measures the total volume of cash and cash equivalents, reflecting the company's ability to fund operating activities without external borrowing. Current cash holdings on GURU.Markets allow for an assessment of the margin of safety for Abeona Therapeutics (ABEO) regarding the commercialization of the Pz-cel drug and FDA approval. A sufficient volume of reserves is critically important for completing gene therapy developments.